Interview with cannabizeu.com regarding Cannabis Anbau-Allianz
In an exclusive conversation with Maik Siebelmann, Head of our Division Pharma, cannabizeucom - one of Europe’s leading news platforms in the cannabis industry - delved into the leading role in cannabis analysis that WESSLING owns in Germany.
As Germany moves towards legalizing recreational cannabis, the expertise of our experts extends into cannabis consulting, analysis, and testing, amplifying our impact in this evolving landscape. Coming from pharmaceutical analysis, our GMP-certified lab in Münster has been a key player in cannabis analysis to ensure product quality and safety.
Quality control for recreational cannabis is paramount, and Maik Siebelmann sheds light on the stringent procedures ensuring adherence to required quality standards. THC/CBD content testing, microbiological analysis, and a wide spectrum of cannabinoids and terpenes are scrutinized.
Adapting to evolving regulations, our experts remain dedicated to setting and upholding regulatory standards for cannabis. We stick to our commitment which is safety, quality, and sustainability - not only for Germany's cannabis market. Read the full article here to discover more on our role in the quality control of cannabis.
Find all information about our services in consulting and analysis of pharmaceutical cannabis here.
Learn more about our services in pharmaceutical cannabis
- Dr. Maik Siebelmann
- +49 251 13 39 880
- pharma@wessling.de
